BACKGROUND: Long-term administration of the antifibrinolytic agent epsilon aminocaproic
acid (EACA) reduces the rate of rehemorrhage in patients with aneurysmal subarachnoid …

Objective: To retrospectively evaluate the utility of serum and cerebrospinal fluid (CSF) levels
of neurofilament light chain (NfL) and phosphorylated neurofilament heavy chain (pNfH) as …

Objective: To determine the safety and tolerability of nusinersen treatment in ambulatory
adults with spinal muscular atrophy (SMA) and investigate the treatment effect on muscle …

Objective: Investigation of the safety, tolerability, and treatment effect of nusinersen
treatment in non-ambulatory adults with spinal muscular atrophy (SMA). Methods: Non-ambulatory …

Objective Spinal muscular atrophy (SMA) is a motor neuron disease caused by low levels of
survival motor neuron (SMN) protein. Prior work in models and patients has demonstrated …

Tumor-associated epilepsy is an important contributor to morbidity in patients with brain tumors.
Proposed pathophysiological mechanisms to explain these effects range from neuronal …

Object Cerebral edema is a significant cause of morbidity and mortality in diverse disease
states. Currently, the means to detect progressive cerebral edema in vivo includes the use of …

Background Glioblastoma multiforme (GBM) is a relentless primary central nervous system
malignancy that remains resistant to conventional therapy despite major advances in clinical …

Peri-infarct increase of vascular density has been observed in animals and in humans with
ischemic stroke. Increased peri-infarct vascular density correlates with improved functional …

Objective To test the hypotheses that decomposition electromyography (dEMG) motor unit
action potential (MUAP) amplitude and firing rate are altered in SMA; dEMG parameters are …